Key Metrics
6.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.98
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Breast cancer
- Lung cancer
- Germline
- Overall survival
- Crizotinib
- Assay
- Progression-free survival
- Epidermal growth factor receptor
- Immunotherapy
- Trametinib
- BRAF V600E
- Toxicity
- RET Fusion
- Alpha diversity
- Prostate cancer
- Glioblastoma
- Homologous recombination
- Precision medicine
- Genomic profiling
- Leiomyosarcoma
Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Continuous publication |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2017 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in JCO Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Prognostic Role of MTAP Loss in Cholangiocarcinoma.
- 1 Jul 25
- JCO precision oncology
-
Full paper
Clinical Significance of TERT Promoter Mutations in Neuroblastoma.
- 1 Jul 25
- JCO precision oncology
-
Full paper
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
- 1 Jul 25
- JCO precision oncology
-
Full paper
Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized Trials.
- 1 Jul 25
- JCO precision oncology
-
Full paper
Consistency and Heterogeneity of Microsatellite Instability (MSI) Status in Paired Biopsy and Surgical Specimens of Colorectal Cancer: A Necessity for MSI Reassessment After Treatment?
- 1 Jul 25
- JCO precision oncology
-
Full paper
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601.
- 1 Jul 25
- JCO precision oncology
FAQs
How long has JCO Precision Oncology been actively publishing?
JCO Precision Oncology has been in operation since 2017 till date.
What is the publishing frequency of JCO Precision Oncology ?
JCO Precision Oncology published with a Continuous publication frequency.
How many articles did JCO Precision Oncology publish last years ?
In 2024, JCO Precision Oncology published 286 articles.
What is the eISSN & pISSN for JCO Precision Oncology ?
For JCO Precision Oncology,eISSN is 2473-4284 and pISSN is2473-4284.
What is Citescore for JCO Precision Oncology ?
Citescore for JCO Precision Oncology is 6.6.
What is SNIP score for JCO Precision Oncology ?
SNIP score for JCO Precision Oncology is 0.98.
Who is the publisher of JCO Precision Oncology ?
LIPPINCOTT WILLIAMS & WILKINS is the publisher of JCO Precision Oncology.